» Articles » PMID: 17967874

Serine 15 Phosphorylation of P53 Directs Its Interaction with B56gamma and the Tumor Suppressor Activity of B56gamma-specific Protein Phosphatase 2A

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2007 Oct 31
PMID 17967874
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Earlier studies have demonstrated a functional link between B56gamma-specific protein phosphatase 2A (B56gamma-PP2A) and p53 tumor suppressor activity. Upon DNA damage, a complex including B56gamma-PP2A and p53 is formed which leads to Thr55 dephosphorylation of p53, induction of the p53 transcriptional target p21, and the inhibition of cell proliferation. Although an enhanced interaction between p53 and B56gamma is observed after DNA damage, the underlying mechanism and its significance in PP2A tumor-suppressive function remain unclear. In this study, we show that the increased interaction between B56gamma and p53 after DNA damage requires ATM-dependent phosphorylation of p53 at Ser15. In addition, we demonstrate that the B56gamma3-induced inhibition of cell proliferation, induction of cell cycle arrest in G(1), and blockage of anchorage-independent growth are also dependent on Ser15 phosphorylation of p53 and p53-B56gamma interaction. Taken together, our results provide a mechanistic link between Ser15 phosphorylation-mediated p53-B56gamma interaction and the modulation of p53 tumor suppressor activity by PP2A. We also show an important link between ATM activity and the tumor-suppressive function of B56gamma-PP2A.

Citing Articles

Novel immune checkpoint-related gene model to predict prognosis and treatment responsiveness in low-grade gliomas.

Guo Y, Bao J, Lin D, Hong K, Cen K, Sun J Heliyon. 2023; 9(9):e20178.

PMID: 37809899 PMC: 10559968. DOI: 10.1016/j.heliyon.2023.e20178.


Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts.

Udroiu I, Marinaccio J, Sgura A FEBS Open Bio. 2023; 13(9):1683-1698.

PMID: 37499040 PMC: 10476563. DOI: 10.1002/2211-5463.13680.


A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Sun X, Dyson H, Wright P Proc Natl Acad Sci U S A. 2021; 118(1).

PMID: 33443163 PMC: 7817127. DOI: 10.1073/pnas.2021456118.


Prognostic Impact of PPP2R5C Gene Expression in Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics.

El Taweel M, Gawdat R, Abdelfattah R Indian J Hematol Blood Transfus. 2020; 36(1):37-46.

PMID: 32158086 PMC: 7042454. DOI: 10.1007/s12288-019-01142-5.


PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer.

Fowle H, Zhao Z, Grana X Adv Cancer Res. 2019; 144:55-93.

PMID: 31349904 PMC: 9994639. DOI: 10.1016/bs.acr.2019.03.009.


References
1.
Li H, Li A, Sheppard H, Liu X . Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression. Mol Cell. 2004; 13(6):867-78. DOI: 10.1016/s1097-2765(04)00123-6. View

2.
Hickson I, Zhao Y, Richardson C, Green S, Martin N, Orr A . Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004; 64(24):9152-9. DOI: 10.1158/0008-5472.CAN-04-2727. View

3.
Margolis S, Perry J, Forester C, Nutt L, Guo Y, Jardim M . Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell. 2006; 127(4):759-73. PMC: 2789796. DOI: 10.1016/j.cell.2006.10.035. View

4.
Muneer S, Ramalingam V, Wyatt R, Schultz R, Minna J, Kamibayashi C . Genomic organization and mapping of the gene encoding the PP2A B56gamma regulatory subunit. Genomics. 2002; 79(3):344-8. DOI: 10.1006/geno.2002.6721. View

5.
Bode A, Dong Z . Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004; 4(10):793-805. DOI: 10.1038/nrc1455. View